Literature DB >> 19959524

MR enterography in the management of patients with Crohn disease.

John R Leyendecker1, Richard S Bloomfeld, David J DiSantis, Gregory S Waters, Ryan Mott, Robert E Bechtold.   

Abstract

Crohn disease is a complex pathologic process with an unpredictable lifelong course that includes frequent relapses. It often affects young patients, who are most vulnerable to the potential adverse effects of repeated exposure to ionizing radiation from computed tomography performed for diagnosis and surgical planning. The small intestine is the bowel segment that is most frequently affected, but it is the least accessible with endoscopic techniques. Magnetic resonance (MR) enterography has the potential to safely and noninvasively meet the imaging needs of patients with Crohn disease without exposing them to ionizing radiation. Appropriate use of MR enterography requires a carefully crafted protocol to depict signs of active inflammation as well as complications such as bowel obstruction, fistulas, and abscesses. Interpretation of MR enterographic images requires familiarity with the imaging signs and mimics of active bowel inflammation and stenosis. Although MR enterography currently is helpful for management in individual patients, the standardization of acquisition protocols and interpretive methods would increase its usefulness for more rigorous, systematic assessments of Crohn disease treatment regimens.

Entities:  

Mesh:

Year:  2009        PMID: 19959524     DOI: 10.1148/rg.296095510

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  35 in total

Review 1.  Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis.

Authors:  Eduardo Garcia Vilela; Henrique Osvaldo da Gama Torres; Fabiana Paiva Martins; Maria de Lourdes de Abreu Ferrari; Marcella Menezes Andrade; Aloísio Sales da Cunha
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

2.  MR enterography versus capsule endoscopy in paediatric patients with suspected Crohn's disease.

Authors:  Emanuele Casciani; Gabriele Masselli; Giovanni Di Nardo; Elisabetta Polettini; Luca Bertini; Salvatore Oliva; Irene Floriani; Salvatore Cucchiara; Gianfranco Gualdi
Journal:  Eur Radiol       Date:  2010-10-05       Impact factor: 5.315

Review 3.  Emergency abdominal MRI: current uses and trends.

Authors:  Hei S Yu; Avneesh Gupta; Jorge A Soto; Christina LeBedis
Journal:  Br J Radiol       Date:  2015-11-19       Impact factor: 3.039

4.  Magnetic resonance enterography: safe and effective imaging for stricturing Crohn's disease.

Authors:  Christina Y Ha; Nitin Kumar; Constantine A Raptis; Vamsi R Narra; Matthew A Ciorba
Journal:  Dig Dis Sci       Date:  2011-06-19       Impact factor: 3.199

5.  Conventional ultrasound and contrast-enhanced ultrasound in evaluating the severity of Crohn's disease.

Authors:  Chang Liu; Xiao-Rong Xu; Hui-Xiong Xu; Zhan-Ju Liu; Yi-Feng Zhang; Li-Ping Sun; Jun-Mei Xu; Lin-Na Liu; Le-Hang Guo; Xiao-Wan Bo
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 6.  Chronic inflammatory diseases of the bowel: diagnosis and follow-up.

Authors:  Guillaume Gorincour; Audrey Aschero; Catherine Desvignes; François Portier; Brigitte Bourlière-Najean; Alix Ruocco-Angari; Philippe Devred; Nathalie Colavolpe; Bertrand Roquelaure; Arnaud Delarue; Philippe Petit
Journal:  Pediatr Radiol       Date:  2010-04-30

Review 7.  An overview of magnetic resonance enterography for Crohn's disease.

Authors:  Suresh Pola; Cynthia Santillan; Barrett G Levesque; Brian G Feagan; William J Sandborn
Journal:  Dig Dis Sci       Date:  2014-09       Impact factor: 3.199

8.  Assessment of patency capsule retention using MR diffusion-weighted imaging.

Authors:  Eyal Klang; Uri Kopylov; Shomron Ben-Horin; Adi Lahat; Doron Yablecovitch; Noa Rozendorn; Rami Eliakim; Michal Marianne Amitai
Journal:  Eur Radiol       Date:  2017-07-04       Impact factor: 5.315

9.  Outcomes of computed tomography and magnetic resonance enterography in clinical practice of inflammatory bowel disease.

Authors:  Niraj S Patel; Suresh Pola; Ramya Muralimohan; G Y Zou; Cynthia Santillan; Derek Patel; Barrett G Levesque; William J Sandborn
Journal:  Dig Dis Sci       Date:  2013-12-10       Impact factor: 3.199

10.  Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients.

Authors:  Mariam Aguas; Guillermo Bastida; Elena Cerrillo; Belén Beltrán; Marisa Iborra; Cristina Sánchez-Montes; Fernando Muñoz; Jesús Barrio; Sabino Riestra; Pilar Nos
Journal:  World J Gastroenterol       Date:  2012-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.